Greenberg Traurig Shareholder David Harburger spoke at the virtual Founder-Led Biotech Summit on Thursday, November 4 at 10 a.m. ET. His session, “Building IP as an Asset”, discussed core inquiries that should be made by bio entrepreneurs early in the company life cycle. Guidance to design, execute, and reassess bio patent estates with the goal of increasing company value, streamlining activity, and setting the stage for successful partnering discussions around intellectual property was outlined. You can listen to the recording of this presentation here.
You May Also Be Interested In: